Startup tests resistance to HIV drugs

June 8, 2014 - Boston Herald

by Marie Szaniszlo

A simple, fast, affordable test developed by a Boston-based MassChallenge finalist is able to determine which drugs HIV is resistant to, saving money and lives.

Using a technology called Pan Degenerate Amplification and Adaptation, Aldatu Biosciences allows doctors to match patients with drugs the HIV won't be resistant to, based on the genetics of the virus.

"If resistance is present, switching people to effective drugs improves quality of life and saves money by reducing the risk of new infections," Aldatu CEO David Raiser said. "If resistance is not present, money is saved by not switching patients to more expensive drugs unnecessarily. There are clear economic and public health benefits to performing the test, regardless of the result." Continue reading...

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in you in box.

seventh name
Sat, 1/31/2015 - 1:12pm
Sat, 1/31/2015 - 2:15am
Thu, 1/29/2015 - 2:33am

Learn about repairing the damage to the immune system caused by HIV, as well as about Immune Reconstitution Inflammation Syndrome (IRIS).

Learn about treatment of hepatitis C – who should get it and what is available – as well as HIV treatment for those infected with hepatitis C.

There are several different options for reducing the chances of passing on HIV while trying to get pregnant. If you are an HIV+ single woman or an HIV+ woman in a same-sex relationship seeking information on getting pregnant, the options below will help you understand what might be the best for you, and to prepare for discussions with your health care provider.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>